Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies
Leila T. Tchelebi(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Nicholas G. Zaorsky(University Hospitals Seidman Cancer Center), Ming Wang(Wannan Medical College), Navesh Sharma(Penn State Milton S. Hershey Medical Center), Emma Batchelder(Penn State Milton S. Hershey Medical Center), Eric J. Lehrer(Icahn School of Medicine at Mount Sinai), Mitchell Machtay(University of Pennsylvania Health System), Daniel M. Trifiletti(Mayo Clinic in Florida), Joseph J. Drabick(Penn State Milton S. Hershey Medical Center)
Cited by 22
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Epidemiology of liver metastases
|Cancer Epidemiology|2020|274
Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck Cancer
|The Oncologist|2008|220
Stroke among cancer patients
|Nature Communications|2019|211